DMKC Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93M Buy
37,496
+7,503
+25% +$605K 0.55% 51
2026
Q1
$2.6M Buy
29,993
+2,367
+9% +$227K 1.08% 41
2025
Q4
$2.65M Buy
27,626
+3,396
+14% +$330K 1.16% 33
2025
Q3
$2.31M Buy
24,230
+208
+0.9% +$19.1K 1.17% 31
2025
Q2
$2.15M Buy
24,022
+3,306
+16% +$280K 1.13% 33
2025
Q1
$1.86M Buy
20,716
+122
+0.6% +$10.9K 1.68% 28
2024
Q4
$1.65M Buy
+20,594
New +$1.78M 1.49% 36

Other funds holding MDT

DMKC Advisory Services's MDT Position: Q2 2026 in Review

DMKC Advisory Services increased its Medtronic (MDT) stake by 25% in Q2 2026, buying an estimated $605K and bringing the position to 37,496 shares worth $2.93M. The position accounts for 0.55% of the portfolio, ranked #51.

DMKC Advisory Services first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • DMKC Advisory Services held 37,496 shares of Medtronic worth $2.93M as of Q2 2026.
  • DMKC Advisory Services bought 7,503 Medtronic shares in Q2 2026, an estimated $605K.
  • Medtronic made up 0.55% of DMKC Advisory Services's portfolio in Q2 2026, its #51 holding.
  • DMKC Advisory Services first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on DMKC Advisory Services's 13F filing for Q2 2026, filed 7 Jul 2026.